The JTO Clinicial and Research Reports (JTOCRR) - YouTube
JTO Clinical and Research Reports
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China - ScienceDirect
Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration
PDF) A Systematic Review and Meta-analysis of Clinical Characteristics and Outcomes in Lung Cancer Patients with COVID-19
Journals | IASLC
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung Cancer - Journal of Thoracic
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study -
Journals | IASLC
Home Page: JTO Clinical and Research Reports
IASLC | International Association for the Study of Lung Cancer
JTO Clinical and Research Reports
JTO Clinical and Research Reports
JTO & JTO CRR on Twitter: "Our Editor-in-Chief, Dr. Alex Adjei, addresses the @IASLC #WCLC19 General Assembly, describing the incredible growth of the JTO (including a new impact factor of 12.460) and
Home Page: JTO Clinical and Research Reports
Journals | IASLC
JTO Clinical and Research Reports | Journal | ScienceDirect.com by Elsevier
Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration
Home Page: JTO Clinical and Research Reports
P088 Distribution of Different HER2 Mutations and Their Impact on Clinical Responses to Afatinib in HER2-Mutant Lung Cancer - Journal of Thoracic Oncology
Home Page: JTO Clinical and Research Reports
Subscribe to Journal of Thoracic Oncology - 1556-0864
JTO Clinical and Research Reports - Journal - Elsevier
